New Delhi, Dr Reddy's Laboratories on Wednesday said it has launched a generic over-the-counter ophthalmic solution for the treatment of itchy eyes in the US after getting approval from the US Food ...

A render of a Formula 1 concept built to the 2026 regulations. Unlike recent arrivals that simply rebranded or took over existing operations, Cadillac is starting from scratch — and history suggests ...

Your device does not support the audio. CHICAGO – Attorney General Kwame Raoul announced that a court dismissed a motion for summary judgment filed by the drugmakers seeking to toss key elements of an ...

When using a compact constructor in a Java record, j2ObjC fails to initialize the record fields in the generated Objective-C code. • Use a canonical constructor instead of a compact constructor. • ...

U.S. District Judge Cynthia Rufe, of the Eastern District of Pennsylvania, gave the claims recovery firms seven days to provide lead counsel with a list of names and contact information for all class ...

WASHINGTON — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians ...

WASHINGTON (AP) — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and ...

Abstract: Usage of artificial intelligence(AI) in automotive and industrial real-time application(like motor fault classification, arc fault detection) [1] has gained ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic versions of Novo Nordisk’s lucrative semaglutide drugs for diabetes and obesity.

The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in. The online health and wellness company is prepping to expand its digital weight loss ...

Hims & Hers Health announced plans to expand to Canada in 2026. Hims will offer generic copies of semaglutide drugs in Canada as Novo Nordisk loses patent protection. Novo Nordisk will lose its patent ...